Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Disease × Rituximab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, Large B-Cell, Diffuse 413 Lymphoma 405 Lymphoma, Non-Hodgkin 342 Leukemia, Lymphocytic, Chronic, B-Cell 313 Lymphoma, Follicular 300 Lymphoma, Mantle-Cell 225 Lymphoma, B-Cell, Marginal Zone 160 Leukemia 119 Lymphoma, B-Cell 111 Burkitt Lymphoma 110 Waldenstrom Macroglobulinemia 99 Precursor Cell Lymphoblastic Leukemia-Lymphoma 90 Recurrence 84 Hodgkin Disease 60 Lymphoma, Large-Cell, Immunoblastic 57 Neoplasms 39 Multiple Myeloma 26 Lymphoma, Large-Cell, Anaplastic 26 Myelodysplastic Syndromes 25 Leukemia, Myeloid, Acute 24 Dendritic Cell Sarcoma, Interdigitating 22 Hematologic Neoplasms 21 Leukemia, Hairy Cell 20 Intraocular Lymphoma 17 Leukemia, Prolymphocytic 16 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 14 Lymphoma, T-Cell 14 Neoplasms, Plasma Cell 13 Hematologic Diseases 13 Lymphoproliferative Disorders 12

Interventions

Blood Specimen Collection 9 Surveys and Questionnaires 6 Magnetic Resonance Spectroscopy 6 Dexamethasone 6 Cyclophosphamide 6 Prednisone 5 Mammography 5 Colonoscopy 5 Biopsy 5 Positron Emission Tomography Computed Tomography 4 Magnetic Resonance Imaging 4 Lenalidomide 4 Biopsy, Fine-Needle 4 pembrolizumab 3 Tomography, X-Ray Computed 3 Surgical Procedures, Operative 3 Melphalan 3 Liquid Biopsy 3 Interviews as Topic 3 Diagnostic Tests, Routine 3 2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 3 weifuchun 2 obinutuzumab 2 fluciclovine F-18 2 daratumumab 2 carfilzomib 2 Urination 2 Preoperative Exercise 2 Positron-Emission Tomography 2 Methods 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01659099 2018-03-07

GAINED

The Lymphoma Academic Research Organisation

Phase 3 Terminated

Disease, Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡